← Leaderboards
Hartmut H Malluche
University Of Kentucky
$9,929,480
Attributed
$10,603,467
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,603,467 · 9
By mechanism
R01$9,656,044 · 4
R56$898,650 · 1
M01$48,773 · 4
Top collaborators
- Nicolae Valentin David2 shared
- Thomas L. Nickolas2 shared
- Isidro B. Benjamin Salusky2 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Julie S Pendergast$3,936,696
- John L Fowlkes$4,123,467
- Michal J. Toborek$37,025,871
- Michael Kilgore$1,153,538
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectOsteoporosisBone LossBoneBone TurnoverQuality Of LifeBone MassBaseLinkBloodMineralsBiopsyMorbidity - Disease RateMeasurementOsteogenesisHistologyBone ResorptionFractureBone DiseasesPhysiciansFundingUnited States National Institutes Of HealthChronic Kidney FailureDialysis Procedure
Grant awards (29)
Novel precision medicine approach to treatment of osteoporosis based on bone turnover$553,303
R01 · FY2024 · AG · contact PI
Novel precision medicine approach to treatment of osteoporosis based on bone turnover$553,303
R01 · FY2023 · AG · contact PI
Renal Osteodystrophy Precision Medicine Project$448,650
R56 · FY2023 · DK
Novel precision medicine approach to treatment of osteoporosis based on bone turnover$553,303
R01 · FY2022 · AG · contact PI
Renal Osteodystrophy Precision Medicine Project$450,000
R56 · FY2022 · DK
Novel precision medicine approach to treatment of osteoporosis based on bone turnover$497,787
R01 · FY2021 · AG · contact PI
Renal Osteodystrophy: A Fresh Approach$582,276
R01 · FY2019 · DK · contact PI
Renal Osteodystrophy: A Fresh Approach$639,633
R01 · FY2018 · DK · contact PI
Renal Osteodystrophy: A Fresh Approach$642,629
R01 · FY2017 · DK · contact PI
Renal Osteodystrophy: A Fresh Approach$641,739
R01 · FY2016 · DK · contact PI
Renal Osteodystrophy: A Fresh Approach$659,076
R01 · FY2015 · DK · contact PI
BISPHOSPHONATE USE AND BONE QUALITY$292,197
R01 · FY2015 · AR · contact PI
BISPHOSPHONATE USE AND BONE QUALITY$320,939
R01 · FY2014 · AR · contact PI
BISPHOSPHONATE USE AND BONE QUALITY$307,559
R01 · FY2013 · AR · contact PI
BISPHOSPHONATE USE AND BONE QUALITY$148,500
R01 · FY2013 · AR · contact PI
BISPHOSPHONATE USE AND BONE QUALITY$325,573
R01 · FY2012 · AR · contact PI
Renal Osteodystrophy: A Fresh Approach$292,860
R01 · FY2012 · DK · contact PI
Renal Osteodystrophy: A Fresh Approach$364,790
R01 · FY2011 · DK · contact PI
Renal Osteodystrophy: A Fresh Approach$495,364
R01 · FY2010 · DK · contact PI
Renal Osteodystrophy: A Fresh Approach$99,716
R01 · FY2010 · DK · contact PI
Renal Osteodystrophy: A Fresh Approach$392,826
R01 · FY2009 · DK · contact PI
RENAL BONE DISEASE$2,739
M01 · FY2007 · RR · contact PI
RENAL BONE DISEASE$15,046
M01 · FY2006 · RR · contact PI
TREATMENT OF CHRONIC HEP C WITH PEG-INTRON AND REBETRON$20,959
M01 · FY2005 · RR
Renal Bone Disease$323,051
R01 · FY2004 · DK
Renal Bone Disease$10,029
M01 · FY2004 · RR
Renal Bone Disease$323,131
R01 · FY2003 · DK
Renal Bone Disease$323,209
R01 · FY2002 · DK
Renal Bone Disease$323,280
R01 · FY2001 · DK